Jianglin Zheng

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: An efficient and safe intranasal drug delivery nanoplatform.

Biomimetic extracellular vesicles derived from chimeric antigen receptor monocytes to treat glioblastoma: An efficient and safe intranasal drug delivery nanoplatform.

Journal: Bioactive materials

Published: February 23, 2025

Corrigendum to "NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization" [Cancer Lett. (2024) 597 217059].

Corrigendum to "NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization" [Cancer Lett. (2024) 597 217059].

Journal: Cancer letters

Published: November 30, 2024

LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF/USP7 axis.

LINC01088 prevents ferroptosis in glioblastoma by enhancing SLC7A11 via HLTF/USP7 axis.

Journal: Clinical and translational medicine

Published: October 11, 2024

NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization.

NSUN4 mediated RNA 5-methylcytosine promotes the malignant progression of glioma through improving the CDC42 mRNA stabilization.

Journal: Cancer letters

Published: March 26, 2024

Comprehensive analysis of cuproptosis-related long non-coding RNAs in prognosis, immune microenvironment infiltration and chemotherapy response of hepatocellular carcinoma.

Comprehensive analysis of cuproptosis-related long non-coding RNAs in prognosis, immune microenvironment infiltration and chemotherapy response of hepatocellular carcinoma.

Journal: Medicine

Published: December 20, 2023

Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma.

Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma.

Journal: Journal of molecular neuroscience : MN

Published: June 07, 2023

Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.

Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m6A-dependent recognition of Nrf2 mRNA mediated by SND1.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 07, 2023

Multi-parametric MRI-based machine learning model for prediction of WHO grading in patients with meningiomas.

Multi-parametric MRI-based machine learning model for prediction of WHO grading in patients with meningiomas.

Journal: European radiology

Published: October 27, 2022

TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion.

TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion.

Journal: Cell death & disease

Published: October 20, 2022

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.

A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma.

Journal: Frontiers in oncology

Published: September 23, 2022

Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network.

Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network.

Journal: Frontiers in immunology

Published: May 14, 2022

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.

Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma.

Journal: Frontiers in genetics

Published: March 21, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026